Masinova Therapeutic Research and Development

Beyond the ordinary

MASINOVA develops rigor-led therapeutic platforms integrating engineered cell therapy, targeted nano-medicine, and Quality-by-Design translational development.

Therapeutic focus:  HIV and oncology

MASINOVA builds preclinical therapeutic platforms designed for disciplined translation from concept to IND-enabling development. My work combines biological innovation with manufacturability, quality systems, and early risk reduction.

 

Platform capabilities: Cell therapy, nanomedicine, translational design

 

  • Engineered cell therapy

  • Targeted nanomedicine

  • QbD-based CMC and translational strategy

 

 

Development stage: Discovery through IND-enabling readiness

I apply Quality-by-Design from the earliest stages of development to improve reproducibility, strengthen decision-making, and support efficient progression toward clinical readiness.